Hot Topics

Biotech

Biotech July 24, 2018

For Applied DNA, ETCH Biotrace may be a pot of gold

By GREGORY ZELLER // Just six months after announcing a partnership to develop a new molecular-tracking system, a Long Island biotech and a Canadian medical-marijuana supplier are launching the world’s first cannabis tagging system. Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist Applied DNA Sciences and Calgary-based pharmaceutical-solutions provider TheraCann International Benchmark Corp. on Tuesday announced the launch of ETCH Biotrace, which leverages Applied DNA’s CertainT platform to tag, test and track cannabis plants “in…

Read More

Biotech April 26, 2018

Grant backs NYU Winthrop’s out-of-the-skull thinking

By GREGORY ZELLER // A “surprise grant” from the Alzheimer’s Disease Resource Center will further some promising Alzheimer’s-related research underway at NYU Winthrop Hospital. The Mineola hospital’s Research Institute announced Wednesday that researcher Allison Reiss, head of the institute’s Inflammation Section, has received a $10,000 grant from ADRC – a Bay Shore-based advocacy group – to support her work with human stem cells. Reiss’ team – including NYU Winthrop researchers Aaron Pinkhasov, Irving Gomolin, Joshua…

Biotech April 5, 2018

Memo to Applied DNA: It’s payday in Pennsylvania

By GREGORY ZELLER // Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid. So, Stony Brook-based Applied DNA Sciences should be very happy to receive the first of two “milestone payments” accompanying the March 31 signing of a new licensing deal with Pennsylvania manufacturer Colorcon Inc. Announced Thursday, the license and cooperation agreement grants Colorcon the exclusive worldwide right to add Applied DNA’s…

Biotech March 20, 2018

Applied DNA won’t let the bed thugs bite

By GREGORY ZELLER // You’ll sleep better knowing your gorgeous new bedding comes from 100 percent source-verified recycled plastic. So say global textiles manufacturer GHCL Ltd. and Applied DNA Sciences, the Stony Brook-based biotech that’s infusing its proprietary CertainT platform into the India-based conglomerate’s new Rekoop brand of bedding products. The CertainT molecular tagging and tracking technology will authenticate recycled plastics being spun into metaphorical gold: GHCL’s Rekoop line of bedsheets, pillowcases and shams, debuting…

Biotech March 7, 2018

Long-lasting glaucoma fix? They can see it from here

By GREGORY ZELLER // A Stony Brook biotech looking to carve a nanotech niche in the science of glaucoma treatment is eyeing some impressive laboratory results. Sustained Nano Systems, working closely with Stony Brook University’s Center for Biotechnology, has “achieved positive in-vitro results on long-term sustained delivery of Latanaprost for glaucoma treatment,” according to a company statement. Decoded: The biotech can keep the No. 1 glaucoma drug ticking for 159 days in in-vitro tests, which…

Biotech March 6, 2018

Applied DNA journeys deeper into India, and pharma

By GREGORY ZELLER // A new professional collaboration will deepen a Long Island biotech’s ties with global pharmaceutical and nutraceutical manufacturers. Stony Brook-based Applied DNA Sciences has signed a memorandum of understanding with India-based global pharmaceutical conglomerate ACG Worldwide, which is tapping into the Long Island firm’s molecular-based authentication services. The MoU – which is “expected to be followed by a definitive agreement,” according to Applied DNA – will apply the biotech’s SigNature molecular tagging…

Biotech February 2, 2018

NIH backs SBU-based biotech’s tuberculosis effort

By GREGORY ZELLER // A Setauket-based pharmaceuticals startup specializing in biomarker analysis has landed a chunky National Institutes of Health research award. Chronus Pharmaceuticals, founded and managed by researchers representing Stony Brook University and an assortment of other prestigious research institutions, announced this week that it has received a $299,172 Phase I Small Business Technology Transfer award from the NIH’s National Institute of Allergy and Infectious Diseases. The award, received in partnership with SBU’s Department…